Reproductive Endocrinology/Infertility

Editor's Choice

Time is of essence when screening for abnormal lipid levels

In spite of public awareness, CVD in women continues to be underdiagnosed and undertreated.

LATEST ARTICLES

Time is of essence when screening for abnormal lipid levels

In spite of public awareness, CVD in women continues to be underdiagnosed and undertreated.

Ob/gyn implications of metabolic syndrome

Beyond overt risks like obesity and diabetes, your patients with features of metabolic syndrome are at risk for more subtle problems--like infertility, pregnancy loss, and polycystic ovarian syndrome.

Q&A: Controversy: Gender selection via preimplantation genetic diagnosis: ethical pros and cons of the controversy

If choosing gender is okay before fertilization, why shouldn't it be with PGD after fertilization, is the thrust of the "pro" argument. The other side calls PGD gender discrimination.

Thyroid Disorders (CE)

After reading this article, pharmacists and technicians should be able to define and describe mechanisms of thyroid dysfunction; describe the pathophysiology, presentation, and diagnosis of thyroid disorders; differentiate between pharmacologic and nonpharmacologic treatment modalities for patients with thyroid disorders; list the medications used in the treatment of hyper- and hypothyroidism; and counsel patients with regard to pregnancy and thyroid disorders.

Endometriosis: Are stem cells to blame?

Dysfunctional stem cells may cause endometriosis posits a new theory. Two experts discuss not only this intriguing theory, but also the latest treatment options, such as aromatase inhibitors, progesterone antagonists, and the levonorgestrel-releasing IUD.